Table A4:
Fraction of trimester opioid exposed on child well-being
| APGAR <7 | CPS in 7 days | NICU Admission | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Full sample | Sibling sample | Full sample | Sibling sample | Full sample | Sibling sample | ||||
|
| |||||||||
| MAT-T1 | 0.003 | 0.005 | −0.026 | 0.095*** | 0.056 | 0.010 | 0.163*** | 0.162*** | 0.081 |
| (0.015) | (0.017) | (0.018) | (0.027) | (0.034) | (0.044) | (0.039) | (0.051) | (0.061) | |
| 1.2% | 2.0% | −10.4% | 67.9% | 18.7% | 3.3% | 16.6% | 13.0% | 6.5% | |
| MAT-T2 | 0.018 | 0.029 | 0.074** | −0.021 | 0.045 | 0.058 | −0.107* | −0.103 | −0.048 |
| (0.022) | (0.027) | (0.031) | (0.048) | (0.062) | (0.077) | (0.060) | (0.076) | (0.091) | |
| 7.2% | 11.6% | 29.6% | −15.0% | 15.0% | 19.3% | −10.9% | −8.2% | −3.8% | |
| MAT-T3 | −0.008 | −0.026 | −0.033 | 0.040 | 0.012 | 0.000 | 0.303*** | 0.287*** | 0.186*** |
| (0.014) | (0.018) | (0.025) | (0.037) | (0.049) | (0.059) | (0.042) | (0.052) | (0.066) | |
| −3.2% | −10.4% | −13.2% | 28.6% | 4.0% | 0.0% | 30.9% | 23.0% | 14.9% | |
| non-MAT-T1 | −0.001 | −0.003 | −0.007 | 0.038*** | 0.036*** | 0.031* | 0.052*** | 0.023 | 0.008 |
| (0.006) | (0.008) | (0.011) | (0.009) | (0.013) | (0.016) | (0.016) | (0.020) | (0.027) | |
| −0.4% | −1.2% | −2.8% | 27.1% | 12.0% | 10.3% | 5.3% | 1.8% | 0.6% | |
| non-MAT-T2 | 0.004 | 0.002 | −0.006 | 0.020 | 0.013 | 0.002 | 0.048** | 0.058** | 0.056 |
| (0.008) | (0.010) | (0.013) | (0.012) | (0.017) | (0.021) | (0.022) | (0.028) | (0.035) | |
| 1.6% | 0.8% | −2.4% | 14.3% | 4.3% | 0.7% | 4.9% | 4.6% | 4.5% | |
| non-MAT-T3 | 0.012* | 0.008 | 0.010 | 0.012 | 0.009 | −0.014 | 0.096*** | 0.088*** | −0.004 |
| (0.007) | (0.009) | (0.010) | (0.010) | (0.014) | (0.016) | (0.017) | (0.023) | (0.030) | |
| 4.8% | 3.2% | 4.0% | 8.6% | 3.0% | −4.7% | 9.8% | 7.0% | −0.3% | |
| Illicit-T1 | −0.014 | −0.005 | −0.028 | 0.154*** | 0.118*** | 0.040 | 0.126*** | 0.121** | 0.073 |
| (0.015) | (0.017) | (0.019) | (0.029) | (0.036) | (0.046) | (0.040) | (0.051) | (0.059) | |
| −5.6% | −2.0% | −11.2% | 110.0% | 39.3% | 13.3% | 12.9% | 9.7% | 5.8% | |
| Illicit-T2 | 0.026 | 0.038 | 0.059* | −0.011 | 0.035 | 0.017 | −0.028 | −0.035 | −0.015 |
| (0.024) | (0.032) | (0.034) | (0.051) | (0.066) | (0.081) | (0.063) | (0.081) | (0.095) | |
| 10.4% | 15.2% | 23.6% | −7.9% | 11.7% | 5.7% | −2.9% | −2.8% | −1.2% | |
| Illicit-T3 | 0.003 | −0.011 | −0.012 | 0.123*** | 0.117* | 0.056 | 0.246*** | 0.282*** | 0.181** |
| (0.020) | (0.028) | (0.033) | (0.047) | (0.064) | (0.074) | (0.054) | (0.071) | (0.086) | |
| 1.2% | −4.4% | −4.8% | 87.9% | 39.0% | 18.7% | 25.1% | 22.6% | 14.5% | |
|
| |||||||||
| Year FE | YES | YES | YES | YES | YES | YES | YES | YES | YES |
| MFE | NO | NO | YES | NO | NO | YES | NO | NO | YES |
| N | 255,227 | 44,838 | 44,838 | 255,227 | 44,838 | 44,838 | 227,053 | 39,575 | 39,575 |